{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:52:34Z","timestamp":1772826754635,"version":"3.50.1"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Invasive group B streptococcal (GBS) disease is the commonest perinatally-acquired bacterial infection in newborns; the burden is higher in African countries where intrapartum antibiotic prophylaxis strategies are not feasible. In sub-Saharan Africa, almost one in four newborns with GBS early-onset disease will demise, and one in ten survivors have moderate or severe neurodevelopmental impairment. A maternal GBS vaccine to prevent invasive GBS disease in infancy is a pragmatic and cost-effective preventative strategy for Africa. Hexavalent polysaccharide protein conjugate and Alpha family surface protein vaccines are undergoing phase II clinical trials. Vaccine licensure may be facilitated by demonstrating safety and immunological correlates\/thresholds suggestive of protection against invasive GBS disease. This will then be followed by phase IV effectiveness studies to assess the burden of GBS vaccine preventable disease, including the effect on all-cause neonatal infections, neonatal deaths and stillbirths.<\/jats:p>","DOI":"10.3389\/fpubh.2023.1214844","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:49:02Z","timestamp":1688017742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Early-onset group B streptococcal disease in African countries and maternal vaccination strategies"],"prefix":"10.3389","volume":"11","author":[{"given":"Ziyaad","family":"Dangor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna C.","family":"Seale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vuyelwa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"ref1","volume-title":"Levels and Trends in Child Mortality","author":"Sharrow","year":"2022"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","article-title":"Global, regional, and national causes of under-5 mortality in 2000-19: an updated systematic analysis with implications for the sustainable development goals","volume":"6","author":"Perin","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e20162013","DOI":"10.1542\/peds.2016-2013","article-title":"Epidemiology of invasive early-onset neonatal Sepsis, 2005 to 2014","volume":"138","author":"Schrag","year":"2016","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12887-019-1866-z","article-title":"Changes in incidence and etiology of early-onset neonatal infections 1997-2017 - a retrospective cohort study in western Sweden","volume":"19","author":"Johansson Gudj\u00f3nsd\u00f3ttir","year":"2019","journal-title":"BMC Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"F248","DOI":"10.1136\/archdischild-2017-314671","article-title":"Early-onset neonatal infections in Australia and New Zealand, 2002-2012","volume":"104","author":"Singh","year":"2019","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1016\/S2214-109X(22)00246-7","article-title":"Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014-19: a cross-sectional study","volume":"10","author":"Mashau","year":"2022","journal-title":"Lancet Glob Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2214-109X(22)00093-6","article-title":"Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden","volume":"10","author":"Gon\u00e7alves","year":"2022","journal-title":"Lancet Glob Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study","volume":"5","author":"Horv\u00e1th-Puh\u00f3","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101358","DOI":"10.1016\/j.eclinm.2022.101358","article-title":"Neurodevelopmental and growth outcomes after invasive group B streptococcus in early infancy: a multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina","volume":"47","author":"Paul","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1093\/cid\/cix585","article-title":"Stillbirth with group B streptococcus disease worldwide: systematic review and Meta-analyses","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/S2214-109X(18)30541-2","article-title":"Causes of stillbirths among women from South Africa: a prospective, observational study","volume":"7","author":"Madhi","year":"2019","journal-title":"Lancet Glob Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1093\/cid\/cix661","article-title":"Preterm birth associated with group B streptococcus maternal colonization worldwide: systematic review and Meta-analyses","volume":"65","author":"Bianchi-Jassir","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12884-021-03624-9","article-title":"Relationship between vaginal group B streptococcus colonization in the early stage of pregnancy and preterm birth: a retrospective cohort study","volume":"21","author":"Tano","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal disease with group B streptococcus and serotype distribution worldwide: systematic review and Meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and Meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review","volume":"65","author":"Le Doare","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1097\/INF.0000000000002695","article-title":"Neurodevelopmental impairment at 1 year of age in infants with previous invasive group B streptococcal Sepsis and meningitis","volume":"39","author":"Nakwa","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1093\/cid\/cix662","article-title":"Neonatal encephalopathy with group B streptococcal disease worldwide: systematic review, Investigator Group datasets, and Meta-analysis","volume":"65","author":"Tann","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41372-021-01290-5","article-title":"The association between early-onset sepsis and neonatal encephalopathy","volume":"42","author":"Car","year":"2022","journal-title":"J Perinatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1086\/376457","article-title":"Prematurity is the major risk factor for late-onset group B streptococcus disease","volume":"188","author":"Lin","year":"2003","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0123014","DOI":"10.1371\/journal.pone.0123014","article-title":"Burden of invasive group B streptococcus disease and early neurological sequelae in south African infants","volume":"10","author":"Dangor","year":"2015","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1093\/cid\/ciab774","article-title":"Prematurity modifies the risk of long-term neurodevelopmental impairments after invasive group B streptococcus infections during infancy in Denmark and the Netherlands","volume":"74","author":"Horv\u00e1th-Puh\u00f3","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s15010-022-01965-x","article-title":"Neonatal invasive disease caused by Streptococcus agalactiae in Europe: the DEVANI multi-center study","author":"Lohrmann","year":"2022","journal-title":"Infection"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1093\/cid\/ciab815","article-title":"Quantifying the acute care costs of neonatal bacterial Sepsis and meningitis in Mozambique and South Africa","volume":"74","author":"Aerts","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/INF.0000000000002500","article-title":"Systematic review on the acute cost-of-illness of Sepsis and meningitis in neonates and infants","volume":"39","author":"Salman","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/bjhp.12572","article-title":"Parents experiences of having an infant with early onset group B streptococcus infection","volume":"27","author":"McLeod","year":"2022","journal-title":"Br J Health Psychol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/S1473-3099(16)30055-X","article-title":"Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis","volume":"16","author":"Kwatra","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12941-019-0313-1","article-title":"Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: a meta-analysis","volume":"18","author":"Gizachew","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e98778","DOI":"10.1371\/journal.pone.0098778","article-title":"Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy","volume":"9","author":"Kwatra","year":"2014","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/cid\/ciaa151","article-title":"Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive group B streptococci within the United States, 2015-2017","volume":"72","author":"McGee","year":"2021","journal-title":"Clin Infect Dis"},{"key":"ref33","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease","volume":"121","author":"Fairlie","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1542\/neo.22-3-e177","article-title":"Updated guidance: prevention and management of perinatal group B streptococcus infection","volume":"22","author":"Dhudasia","year":"2021","journal-title":"NeoReviews"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e018795","DOI":"10.1136\/bmjopen-2017-018795","article-title":"Early-onset group B streptococcus (EOGBS) infection subsequent to cessation of screening-based intrapartum prophylaxis: findings of an observational study in West London, UK","volume":"7","author":"Gopal Rao","year":"2017","journal-title":"BMJ Open"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/archdischild-2016-311419","article-title":"Challenges in reducing group B streptococcus disease in African settings","volume":"102","author":"Nishihara","year":"2017","journal-title":"Arch Dis Child"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/AOG.0000000000003057","article-title":"Point-of-care intrapartum group B streptococcus molecular screening: effectiveness and costs","volume":"133","author":"El Helali","year":"2019","journal-title":"Obstet Gynecol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/01443615.2017.1328490","article-title":"Screening for group B streptococcus (GBS) at labour onset using PCR: accuracy and potential impact - a pilot study","volume":"38","author":"Ramesh Babu","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.midw.2021.103208","article-title":"Probiotic interventions to reduce antepartum group B streptococcus colonization: a systematic review and meta-analysis","volume":"105","author":"Hanson","year":"2022","journal-title":"Midwifery"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e0017021","DOI":"10.1128\/Spectrum.00170-21","article-title":"Garlic: an alternative treatment for group B streptococcus","volume":"9","author":"Torres","year":"2021","journal-title":"Microbiol Spectr"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12866-021-02428-3","article-title":"The antimicrobial activity of zinc against group B streptococcus is strain-dependent across diverse sequence types, capsular serotypes, and invasive versus colonizing isolates","volume":"22","author":"Francis","year":"2022","journal-title":"BMC Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ajog.2021.10.041","article-title":"Maternal vaccination: a review of current evidence and recommendations","volume":"226","author":"Etti","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"704254","DOI":"10.3389\/fimmu.2021.704254","article-title":"Associations between maternal immunisation and reduced rates of preterm birth and stillbirth: a population based retrospective cohort study","volume":"12","author":"Giles","year":"2021","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet (London, England)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/jamapediatrics.2016.0921","article-title":"Duration of infant protection against influenza illness conferred by maternal immunization: secondary analysis of a randomized clinical trial","volume":"170","author":"Nunes","year":"2016","journal-title":"JAMA Pediatr"},{"key":"ref49","volume-title":"Group B Streptococcus Vaccine Development Technology Roadmap. Priority Activities for Development, Testing, Licensure and Global Availability of Group B Streptococcus Vaccines","year":"2017"},{"key":"ref50","volume-title":"WHO Preferred Product Characteristics for Group B Streptococcus Vaccines","year":"2017"},{"key":"ref51","volume-title":"Group B Streptococcus Vaccine: Full Value of Vaccine Assessment. Executive Summary","year":"2021"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/aogs.13288","article-title":"Antenatal vaccination against group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation","volume":"97","author":"McQuaid","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e1004068","DOI":"10.1371\/journal.pmed.1004068","article-title":"Maternal immunisation against group B streptococcus: a global analysis of health impact and cost-effectiveness","volume":"20","author":"Procter","year":"2023","journal-title":"PLoS Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"6238","DOI":"10.1016\/j.vaccine.2017.08.085","article-title":"Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States","volume":"35","author":"Kim","year":"2017","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1016\/j.vaccine.2017.07.108","article-title":"Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa","volume":"35","author":"Russell","year":"2017","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1016\/j.vaccine.2020.02.071","article-title":"Potential cost-effectiveness of a maternal group B streptococcal vaccine in the Gambia","volume":"38","author":"Ahmed","year":"2020","journal-title":"Vaccine"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"ofaa634","DOI":"10.1093\/ofid\/ofaa634","article-title":"Low but increasing prevalence of reduced Beta-lactam susceptibility among invasive group B streptococcal isolates, US population-based surveillance, 1998-2018","volume":"8","author":"Kobayashi","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"568.e13","DOI":"10.1016\/j.cmi.2015.01.030","article-title":"Natural acquired humoral immunity against serotype-specific group B streptococcus rectovaginal colonization acquisition in pregnant women","volume":"21","author":"Kwatra","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1586\/14760584.2014.953939","article-title":"Review on the association of group B streptococcus capsular antibody and protection against invasive disease in infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/QCO.0000000000000266","article-title":"Group B streptococcus: developing a correlate of protection for a vaccine against neonatal infections","volume":"29","author":"Dangor","year":"2016","journal-title":"Curr Opin Infect Dis"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1016\/S1473-3099(18)30659-5","article-title":"Serocorrelates of protection against infant group B streptococcus disease","volume":"19","author":"Le Doare","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1093\/cid\/ciaa1873","article-title":"Association of group B streptococcus serum serotype-specific anti-capsular IgG concentration and risk reduction for invasive group B streptococcus disease in south African infants: an observational birth-cohort, matched case-control study","volume":"73","author":"Madhi","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.vaccine.2023.01.071","article-title":"Association of infant rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive group B streptococcal disease in young infants","volume":"41","author":"Dangor","year":"2023","journal-title":"Vaccine"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/infdis\/jit549","article-title":"Maternal antibody at delivery protects neonates from early onset group B streptococcal disease","volume":"209","author":"Baker","year":"2014","journal-title":"J Infect Dis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/cid\/ciw377","article-title":"The protective value of maternal group B streptococcus antibodies: quantitative and functional analysis of naturally acquired responses to capsular polysaccharides and pilus proteins in European maternal sera","volume":"63","author":"Fabbrini","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"6813","DOI":"10.1016\/j.vaccine.2021.10.022","article-title":"Infant serotype specific anti-capsular immunoglobulin G antibody and risk of invasive group B streptococcal disease","volume":"39","author":"Dangor","year":"2021","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/14760584.2018.1496021","article-title":"Systematic review of the clinical development of group B streptococcus serotype-specific capsular polysaccharide-based vaccines","volume":"17","author":"Dzanibe","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.2147\/IDR.S203454","article-title":"A vaccine against group B streptococcus: recent advances","volume":"13","author":"Carreras-Abad","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/pathogens12020229","article-title":"Strategies to prevent early and late-onset group B Streptococcal infection via interventions in pregnancy","volume":"12","author":"Delara","year":"2023","journal-title":"Pathogens"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1056\/NEJM198811033191802","article-title":"Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus","volume":"319","author":"Baker","year":"1988","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/S0264-410X(03)00353-0","article-title":"Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine","volume":"21","author":"Baker","year":"2003","journal-title":"Vaccine"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/AOG.0000000000001190","article-title":"Maternal immunization with an investigational trivalent group B streptococcal vaccine: a randomized controlled trial","volume":"127","author":"Donders","year":"2016","journal-title":"Obstet Gynecol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","article-title":"Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial","volume":"16","author":"Heyderman","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.1016\/j.vaccine.2020.08.056","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: results from a randomized placebo-controlled phase II trial","volume":"38","author":"Swamy","year":"2020","journal-title":"Vaccine"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jinf.2018.01.006","article-title":"Functional activity of maternal and cord antibodies elicited by an investigational group B streptococcus trivalent glycoconjugate vaccine in pregnant women","volume":"76","author":"Fabbrini","year":"2018","journal-title":"J Infect"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody kinetics and response to routine vaccinations in infants born to women who received an investigational trivalent group B streptococcus polysaccharide CRM197-conjugate vaccine during pregnancy","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciy838","article-title":"A phase 2, randomized, control trial of group B streptococcus (GBS) type III capsular polysaccharide-tetanus toxoid (GBS III-TT) vaccine to prevent vaginal colonization with GBS III","volume":"68","author":"Hillier","year":"2019","journal-title":"Clin Infect Dis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/ciz360","article-title":"The association between breast Milk group B streptococcal capsular antibody levels and late-onset disease in young infants","volume":"70","author":"Dangor","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1473-3099(20)30478-3","article-title":"Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1\/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial","volume":"21","author":"Absalon","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1016\/j.vaccine.2019.04.039","article-title":"The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations","volume":"37","author":"Vekemans","year":"2019","journal-title":"Vaccine"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"B112","DOI":"10.1016\/j.vaccine.2009.04.065","article-title":"Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"ref85","first-page":"36","volume-title":"Vaccines and Biologicals W. Measuring Impact of Streptococcus Pneumoniae and","year":"2012"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","article-title":"Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against group B streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women","volume":"39","author":"Fischer","year":"2021","journal-title":"Vaccine"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"106261","DOI":"10.1016\/j.isci.2023.106261","article-title":"Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial","volume":"26","author":"Gonzalez-Miro","year":"2023","journal-title":"iScience"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MOP.0000000000001223","article-title":"20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention","volume":"35","author":"Paul","year":"2023","journal-title":"Curr Opin Pediatr"},{"key":"ref89","volume-title":"The 2017 National Antenatal Sentinel HIV Survey","author":"Woldesenbet","year":"2019"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"13820","DOI":"10.1038\/s41598-017-13218-1","article-title":"Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis","volume":"7","author":"Cools","year":"2017","journal-title":"Sci Rep"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00431-022-04710-6","article-title":"Increased risk of group B streptococcal sepsis and meningitis in HIV-exposed uninfected infants in a high-income country","volume":"182","author":"Manzanares","year":"2023","journal-title":"Eur J Pediatr"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/infdis\/jiv064","article-title":"HIV-1 is associated with lower group B streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women","volume":"212","author":"Dangor","year":"2015","journal-title":"J Infect Dis"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/infdis\/jiw566","article-title":"Reduced transplacental transfer of group B streptococcus surface protein antibodies in HIV-infected mother-Newborn dyads","volume":"215","author":"Dzanibe","year":"2017","journal-title":"J Infect Dis"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1086\/519845","article-title":"Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya","volume":"196","author":"Cumberland","year":"2007","journal-title":"J Infect Dis"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1016\/j.vaccine.2015.07.108","article-title":"Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries","volume":"33","author":"White","year":"2015","journal-title":"Vaccine"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1016\/j.vaccine.2018.06.001","article-title":"Using pneumococcal and rotavirus surveillance in vaccine decision-making: a series of case studies in Bangladesh, Armenia and the Gambia","volume":"36","author":"Hasan","year":"2018","journal-title":"Vaccine"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1214844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T05:49:09Z","timestamp":1688017749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1214844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":98,"alternative-id":["10.3389\/fpubh.2023.1214844"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1214844","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"article-number":"1214844"}}